La ferritina sérica: más allá de la deficiencia de hierro
Descargas
Referencias bibliográficas
Ogilvie C, Fitzsimons K, Fitzsimons EJ. Serum ferritin values in primary care: are high values overlooked? J Clin Pathol 2010;63:1124-1126.
https://doi.org/10.1136/jcp.2010.083188
Ho CH. The differential diagnostic values of serum transferrin receptor, serum ferritin and related parameters in the patients with various causes of anemia. Haematologica 2001;86:206-207.
Birgegard G, Hallgren R, Killander A, Stromberg A, Venge P, Wide L. Serum ferritin during infection. A longitudinal study. Scand J Haematol 1978;21:333-340.
https://doi.org/10.1111/j.1600-0609.1978.tb00374.x
Herbert V, Jayatilleke E, Shaw S, Rosman AS, Giardina P, Grady RW, et al. Serum ferritin iron, a new test, measures human body iron stores unconfounded by inflammation. Stem Cells 1997;15:291-296.
https://doi.org/10.1002/stem.150291
Seyhan S, Pamuk ON, Pamuk GE, Cakir N. The correlation between ferritin level and acute phase parameters in rheumatoid arthritis and systemic lupus erythematosus. Eur J Rheumatol 2014;1:92-95.
https://doi.org/10.5152/eurjrheumatol.2014.032
Thachil J. The beneficial effect of acute phase increase in serum ferritin. Eur J Intern Med 2016;35:e16-e17.
https://doi.org/10.1016/j.ejim.2016.07.020
Moirand R, Mortaji AM, Loreal O, Paillard F, Brissot P, Deugnier Y. A new syndrome of liver iron overload with normal transferrin saturation. Lancet 1997;349:95-97.
https://doi.org/10.1016/S0140-6736(96)06034-5
Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005;9:37-53.
https://doi.org/10.1016/j.cld.2004.11.001
Yip WW, Burt AD. Alcoholic liver disease. Semin Diagn Pathol 2006;23:149-160.
https://doi.org/10.1053/j.semdp.2006.11.002
Wu J, Chen L, Chen Y, Yang J, Wu D. Serum ferritin concentration predicts mortality in patients with hepatitis B virus-related acute on chronic liver failure. Arch Med Res 2014;45:251-256.
https://doi.org/10.1016/j.arcmed.2014.03.004
Ferrara F, Ventura P, Vegetti A, Guido M, Abbati G, Corradini E, et al. Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C. Am J Gastroenterol 2009;104:605-616.
https://doi.org/10.1038/ajg.2008.126
Uchino K, Tateishi R, Fujiwara N, Minami T, Sato M, Enooku K, et al. Impact of serum ferritin level on hepatocarcinogenesis in chronic hepatitis C patients. Hepatol Res 2016;46:259-268.
https://doi.org/10.1111/hepr.12517
McLaren GD, Gordeuk VR. Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Hematology Am Soc Hematol Educ Program 2009;195-206.
https://doi.org/10.1182/asheducation-2009.1.195
Mathurin P, Beuzin F, Louvet A, Carrie-Ganne N, Balian A, Trinchet JC, et al. Fibrosis progression occurs in a subgroup of heavy drinkers with typical histological features. Aliment Pharmacol Ther 2007;25:1047-1054.
https://doi.org/10.1111/j.1365-2036.2007.03302.x
Carithers RL, McClain CJ. Alcoholic liver disease. In: Sleisenger and Fordtran's Gastrointestinal and liver disease pathophysiology diagnosis management, edited by Feldman M, Friedman LS, Brandt LJ. Philadelphia: Saunders Elsevier, 2016, p. 1409-1427.
Huang J, Jones D, Luo B, Sanderson M, Soto J, Abel ED, et al. Iron overload and diabetes risk: a shift from glucose to Fatty Acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes 2011;60:80-87.
https://doi.org/10.2337/db10-0593
Creighton Mitchell T, McClain DA. Diabetes and hemochromatosis. Curr Diab Rep 2014;14:488.
https://doi.org/10.1007/s11892-014-0488-y
Campuzano-Maya G. Estudio del paciente con hiperferritinemia. Medicina & Laboratorio 2017;23:411-442.